Analysts have clear opinions on OSUR.

There are 1 analyst offering 12 month price targets for Orasure Technologies in the last 3 months. The average price target is $8.00 with a high forecast of $8.00 and a low forecast of $8.00. The average price target represents a -1.60% decrease from the last price of $8.13.
OraSure Technologies, Inc. (OSUR) is followed by 1 analysts on the street.

Mark Massaro from Canaccord Genuity rates it a Hold with a target of $8.00.

Similarly, null null of null null a null with a target of null.

The consensus on the street is Hold.

What does OraSure Technologies, Inc.(OSUR) do ?
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices. The DNAG segment manufactures and sells specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.

OraSure Technologies, Inc. (OSUR) Insider Trades

Multiple company employees have indulged in significant insider trading. OraSure Technologies, Inc. disclosed the following in a document filed with the US Securities and Exchange Commission (SEC):

Pres, CEO, Tang Stephen S Phd : P – Purchase(+$8,560) of OSUR in the trading session of 2019-05-14.

SVP,amp; GC Jerrett Jack E : P – Purchase(+$85,487) of OSUR in the trading session of 2019-05-13.

CFO Cuca Roberto : P – Purchase(+$90,314) of OraSure Technologies, Inc. in the trading session of 2019-05-10.

Looking for stocks just like OSUR?

Based on Wall Street analyst research, several stocks are similar to OSUR
They are:
– CEMI [Info can be found here: https://www.nasdaq.com/market-activity/stocks/CEMI ]
– TMO [Info can be found here: https://www.nasdaq.com/market-activity/stocks/TMO ]
– QDEL [Info can be found here: https://www.nasdaq.com/market-activity/stocks/QDEL ]
Analysts have clear opinions on NWBI.

There are 2 analysts on the Wall offering 12 month price targets for Northwest Bancshares in the last 3 months. The average price target is $15.50 with a high forecast of $15.50 and a low forecast of $15.50. The average price target represents a -4.38% decrease from the last price of $16.21.
Northwest Bancshares, Inc. (NWBI) is followed by 2 analysts on the street.

Frank Schiraldi from Piper Sandler rates it a Sell with a target of $15.50.

Similarly, 2 months ago David Long of Raymond James Initiated a Hold with a target of —.

The consensus on the street is Moderate Sell.

What does Northwest Bancshares, Inc.(NWBI) do ?
Northwest Bancshares, Inc. is a holding company. It offers personal & business banking products including employee benefits, investment management services, insurance and trust. It engages in collecting deposits and making loans secured by various types of collateral, including real estate and other assets. The company was founded on June 29, 2001 and is headquartered in Warren, PA.

Northwest Bancshares, Inc. (NWBI) Insider Trades

Multiple company employees have indulged in significant insider trading. Northwest Bancshares, Inc. disclosed the following in a document filed with the US Securities and Exchange Commission (SEC):

EVP, HR, McTavish Julia W : S – Sale+OE(-$147,656) of NWBI in the trading session of 2020-01-15.

EVP, Chief Credit Officer Smelko Michael G : S – Sale+OE(-$214,711) of NWBI in the trading session of 2019-12-09.

EVP, Chief Credit Officer Smelko Michael G : S – Sale+OE(-$1,035,394) of Northwest Bancshares, Inc. in the trading session of 2019-12-06.